Sheng Wang

Chongqing, 400030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Organoids in cancer therapy: translational applications and clinical promise.

Organoids in cancer therapy: translational applications and clinical promise.

Journal: Molecular cancer
Published: January 29, 2026

m6A-dependent translation of circPICALM encodes a novel metastasis-promoting oncoprotein in intrahepatic cholangiocarcinoma.

m6A-dependent translation of circPICALM encodes a novel metastasis-promoting oncoprotein in intrahepatic cholangiocarcinoma.

Journal: Molecular cancer
Published: July 09, 2025

DCM-Net: dual-encoder CNN-Mamba network with cross-branch fusion for robust medical image segmentation.

DCM-Net: dual-encoder CNN-Mamba network with cross-branch fusion for robust medical image segmentation.

Journal: BMC medical imaging
Published: May 27, 2025

Development and validation of a nomogram to predict prognosis of patients with combined hepatocellular-cholangiocarcinoma after hepatic resection.

Development and validation of a nomogram to predict prognosis of patients with combined hepatocellular-cholangiocarcinoma after hepatic resection.

Journal: Journal of Cancer
Published: May 01, 2025

The function of NAT10-driven N4-acetylcytidine modification in cancer: novel insights and potential therapeutic targets.

The function of NAT10-driven N4-acetylcytidine modification in cancer: novel insights and potential therapeutic targets.

Journal: Cell & bioscience
Published: April 03, 2025

Developing a Prognostic Model for Intrahepatic Cholangiocarcinoma Patients With Elevated Preoperative Carbohydrate Antigen 19-9 Levels: Volume-Adjusted CA19-9 (VACA) as a Novel Biomarker.

Developing a Prognostic Model for Intrahepatic Cholangiocarcinoma Patients With Elevated Preoperative Carbohydrate Antigen 19-9 Levels: Volume-Adjusted CA19-9 (VACA) as a Novel Biomarker.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: February 13, 2025

Geriatric nutritional risk index and body composition dictate the prognosis of elderly patients with intrahepatic cholangiocarcinoma.

Geriatric nutritional risk index and body composition dictate the prognosis of elderly patients with intrahepatic cholangiocarcinoma.

Journal: Frontiers in nutrition
Published: January 23, 2025

Tumour burden score combined with albumin-to-alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma.

Tumour burden score combined with albumin-to-alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma.

Journal: Journal of cellular and molecular medicine
Published: May 03, 2024
Showing 1-8 of 8

Last Updated: 09/26/2026